gemcitabine
A 2'-deoxycytidine having geminal fluoro substituents in the 2'-position. An inhibitor of ribonucleotide reductase, gemcitabine is used in the treatment of various carcinomas, particularly non-small cell lung cancer, pancreatic cancer, bladder cancer and breast cancer.
Term info
gemcitabine
- 2'-deoxy-2',2'-difluorocytidine
3_STAR
0
C9H11F2N3O4
CHEBI:42752, CHEBI:5295
chebi_ontology
2',2'-Difluorodeoxycytidine, 2'-Deoxy-2',2'-difluorocytidine, gemcitabina, gemcitabinum, 4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one, gemcitabine
CHEBI:175901
InChI=1S/C9H11F2N3O4/c10-9(11)6(16)4(3-15)18-7(9)14-2-1-5(12)13-8(14)17/h1-2,4,6-7,15-16H,3H2,(H2,12,13,17)/t4-,6-,7-/m1/s1
SDUQYLNIPVEERB-QPPQHZFASA-N
263.19810
263.07176
Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1
Term relations
- pyrimidine 2'-deoxyribonucleoside
- organofluorine compound
- has role some EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor
- has role some antiviral drug
- has role some immunosuppressive agent
- has role some xenobiotic
- has role some prodrug
- has role some antineoplastic agent
- has role some DNA synthesis inhibitor
- has role some environmental contaminant
- has role some radiosensitizing agent
- has role some antimetabolite
- has role some photosensitizing agent